Skip to main content
SpringerLink
Log in

The rt-PA for Acute Stroke Protocol

  • Chapter
Thrombolytic Therapy for Acute Stroke

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

To successfully identify, triage, diagnose, and treat an acute stroke victim in time requires a coordinated, multidisciplinary effort that is organized around a predefined protocol. The protocol assures that all needed action will occur in a timely fashion. Also, the ratio of stroke to stroke-mimics may be one to four or five, which mandates the presence of an efficient, skilled procedure for eliminating the mimics (e.g., Todd’s paralysis, transient ischemic attack, hysteria, migraine, and carpal tunnel syndrome). Stroke patients must be stabilized according to basic protocols (Airway, Breathing, Circulation) before the neurological evaluation begins; this process should require no more than 1 or 2 min. Stroke management then includes diagnosis and possibly treatment. All of the above is best accomplished with a institutionalized stroke team, comparable to a code blue team that rehearses, monitors performance, and uses feedback to continually improve care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brott TG, Haley EC, Jr., Levy DE, et al. Urgent therapy for stroke: part 1. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23:632–640.

    PubMed  CAS  Google Scholar 

  2. Brott T, Haley EC, Levy DE, et al. Very early therapy for cerebral infarction with tissue plasminogen activator (tPA). Stroke 1988; 19:8.

    Google Scholar 

  3. Haley EC, Jr., Levy DE, Brott TG, et al. Urgent therapy for stroke: part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992; 23:641–645.

    PubMed  Google Scholar 

  4. Haley EC, Brott TG, Sheppard GL, et al. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 1993; 24:1000–1004.

    PubMed  Google Scholar 

  5. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 1999; 340:1781–1787.

    Article  PubMed  CAS  Google Scholar 

  6. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333(24):1581–1587.

    Article  Google Scholar 

  7. NINDS rt-PA Stroke Study Group. Generalized efficacy of t-PA for aAcute stroke. Stroke 1997;28:2119–2125.

    Google Scholar 

  8. NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997; 28:2109–2118.

    Google Scholar 

  9. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Thrombolytic therapy for acute ischemic stroke—summary statement. Neurology 1996; 47:835–839.

    Google Scholar 

  10. Adams HP, Jr., Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Circulation 1996;94:1167–1174.

    PubMed  Google Scholar 

  11. Adams HP, Jr., Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34(4):1056–1083.

    Article  PubMed  Google Scholar 

  12. Tilley BC, Lyden PD, Brott TG, et al. Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. Arch Neurol 1997; 54:1466–1474.

    PubMed  CAS  Google Scholar 

  13. Lyden PD, Rapp K, Babcock T, Rothrock J. Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials. J Stroke Cerebrovasc Dis 1994; 4:106–113.

    Article  Google Scholar 

  14. Saver JL, Kidwell C, Eckstein M, Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004;35(5):e106–e108.

    Article  PubMed  CAS  Google Scholar 

  15. Timerding BL, Barsan WG, Hedges JR, et al. Stroke patient evaluation in the emergency department before pharmacologic therapy. Am J Emerg Med 1989; 7:11–15.

    Article  PubMed  CAS  Google Scholar 

  16. Myers MG, Norris JW, Hachinski VC, Weingert ME, Sole MJ. Cardiac sequelae of acute stroke. Stroke 1982; 13:838–842.

    PubMed  CAS  Google Scholar 

  17. Grotta J, Spydell J, Prettigrew LC, Ostrow P, Hunter D. The effect of nicardipine on neuronal function following ischemia. Stroke 1986; 17:213–219.

    PubMed  CAS  Google Scholar 

  18. Fagan SC, Bowes MP, Lyden PD, Zivin JA. Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: effect of labetalol. Exp Neurol 1998; 150:153–158.

    Article  PubMed  CAS  Google Scholar 

  19. Bowes MP, Zivin JA, Thomas GR, Thibodeaux H, Fagan SC. Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits. Exp Neurol 1996; 141:40–46.

    Article  PubMed  CAS  Google Scholar 

  20. Levy DE, Brott TG, Haley EC, Jr., et al. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994; 25:291–297.

    PubMed  CAS  Google Scholar 

  21. Brott T, Lu M, Kothari R, et al. Hypertension and its treatment in the NINDS rt-PA stroke trial. Stroke 1998; 29:1504–1509.

    PubMed  CAS  Google Scholar 

  22. Graham GD. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Stroke 2003; 34(12): 2847–2850.

    Article  PubMed  CAS  Google Scholar 

  23. Chiu D, Krieger D, Villar-Cordova C, et al. Intravenous tissue plasminogen activator for acute ischemic stroke feasibility, safety, and efficacy in the first year of clinical practice. Stroke 1998; 29:18–22.

    PubMed  CAS  Google Scholar 

  24. Tanne D, Bates V, Verro P, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. Neurology 1999; 53:424–427.

    PubMed  CAS  Google Scholar 

  25. Lacy CR, Suh D-C, Bueno M, Kostis JB. Delay in presentation and evaluation for acute stroke. Stroke 2001; 32:63–69.

    PubMed  CAS  Google Scholar 

  26. Harper GD, Haigh RA, Potter JF, Castleden CM. Factors delaying hospital admission after stroke in leicestershire. Stroke 1992; 23:835–838.

    PubMed  CAS  Google Scholar 

  27. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992; 23:352–356.

    PubMed  CAS  Google Scholar 

  28. Pancioli AM, Broderick J, Kothari R, et al. Public perception of stroke warning signs and knowledge of potential risk factors. JAMA 1998; 279(16):1288–1292.

    Article  PubMed  CAS  Google Scholar 

  29. Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston, Texas. Stroke 1995; 26:409–414.

    PubMed  CAS  Google Scholar 

  30. Lyden PD, Zivin JA. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence. Cerebrovasc Brain Met Rev 1993; 5:1–16.

    CAS  Google Scholar 

  31. Lapchak PA. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment. Curr Neurol Neurosci Rep 2002; 2(1):38–43.

    Article  PubMed  Google Scholar 

  32. Hallenbeck JM, Frerichs KU. Stroke therapy. It may be time for an integrated approach. Arch Neurology 1993; 50:768–770.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroscience Center, National Institute of Neurological Disorders and Stroke, Rockville, MD

    John Marler MD

  2. UCSD Stroke Center, University of California, San Diego, and Veteran’s Affairs Medical Center, San Diego, CA

    Patrick D. Lyden MD

Authors
  1. John Marler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick D. Lyden MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. USCD Stroke Center, University of California, San Diego

    Patrick D. Lyden MD

  2. Veteran’s Affairs Medical Center, San Diego, CA

    Patrick D. Lyden MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Marler, J., Lyden, P.D. (2005). The rt-PA for Acute Stroke Protocol. In: Lyden, P.D. (eds) Thrombolytic Therapy for Acute Stroke. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-933-8:299

Download citation

  • DOI: https://doi.org/10.1385/1-59259-933-8:299

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-398-5

  • Online ISBN: 978-1-59259-933-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation